Cancer risk awareness and concern among women with a family history of breast or ovarian cancer

Behavioral Medicine

Volumn 42, Issue 1, 2016, Pages 18-28

  Andersen, M Robyn ^a   Thorpe, Jason ^b   Buist, Diana S M ^c   Beatty, J David ^b   Watabayashi, Kate ^b   Hanson, Nancy ^d   Resta, Robert ^d   Chubak, Jessica ^c   Urban, Nicole ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b USA   (United States)

^c GROUP HEALTH RESEARCH INSTITUTE   (United States)

^d Swedish Hospital   (United States)

Author keywords

breast cancer risk; genetics; ovarian cancer; worry

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; PROTEIN P53;

ADULT; AGED; ARTICLE; AWARENESS; BREAST CANCER; CANCER RISK; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; HEALTH EDUCATION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MAMMOGRAPHY SYSTEM; OVARY CANCER; PATIENT REFERRAL; RISK MANAGEMENT; SECOND DEGREE RELATIVE; THIRD DEGREE RELATIVE; ATTITUDE TO HEALTH; BREAST TUMOR; FAMILY HEALTH; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; OVARY TUMOR; PSYCHOLOGY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR;

ADULT; AGED; BREAST NEOPLASMS; FAMILY HEALTH; FEMALE; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SURVEYS AND QUESTIONNAIRES;

EID: 84956592163     PISSN: 08964289     EISSN: 19404026     Source Type: Journal    
DOI: 10.1080/08964289.2014.947234     Document Type: Article

References (31)

1. Bast RC Jr., Brewer M., Zou C, et al.: Prevention and early detection of ovarian cancer: mission imposible ? Recent Results Cancer Res. 2007; 174: 91-1000
2. Lux MP., Fasching PA., Bechman MW.: Hereditary breast and ovarian cancer: review and future perspectives. J Molecular Med. 2006; 84: 16-28
3. Foulkes W., Glendon G., Narod S.: Family history and risk of ovarian cancer. JAMA. 1995; 274: 383
4. Frank TS, et al.: Sequence analyses of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J Clin Oncol. 1998; 16: 2417-2425
5. Howlader N NA., Krapcho M., Neyman N., Aminou R., Altekruse SF., Kosary CL., Ruhl J., Tatalovich Z., Cho H., Mariotto A., Eisner MP., Lewis DR., Chen HS., Feuer EJ., Cronin KA. (eds). SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations). Bethesda, MD: National Cancer Institute. http://seer.cancer.gov/csr/1975-2009-pops09/.
6. Powell CB., Kenley E., Chen LM, et al.: Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy. J Clin Oncol. 2005; 23: 127-132
7. Burke W., Daly M., Garber J, et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. JAMA. 1997; 277: 997-1003
8. Burke W., Culber JO., Bowen D, et al. Genetic counseling for women with an intermediate family history of breast cancer. Am J Med Genetics. 2000; 90: 361-368
9. Struewing JP., Watson P., Easton DF., Ponder BA., Lynch HT., Tucker MA. Prophylactic oophorectomy in inherited breast/ovarian cancer families. J Natl Cancer Inst. 1995; 17: 3305
10. Rebbeck TR., Lynch HT., Neuhausen SL, et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med. 2002; 346: 1616-1622
11. Berek JS., Chalas E., Edelson M, et al. Prophylactic and risk-reducing bilateral salpingo-oophorectomy: recommendations based on risk of ovarian cancer. Obstet Gynecol. 2010; 116: 733-743
12. Stirling D., Evan DGR., Pichert G, et al. Screening for familial ovarian cancer: failure of current protocols to detect ovarian cancer at an early stage according to the international federation of Gynecology and Obstetrics System. J Clin Oncol. 2005; 23: 5588-5596
13. Buys SS., Partridge E., Black A, et al. Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA. 2011; 305: 2295-2303
14. Cragun JM. Screening for ovarian cancer. Cancer Control. 2011; 18: 16-21
15. Schorge JO., Modesitt SC., Coleman RL, et al. SGO White Paper on ovarian cancer: etiology, screening and surveillance. Gynecol Oncol. 2010; 119: 7-17
16. Singh RB., Niaz MA., Ghosh S. Hypolipidemic and antioxidant effects of Commiphora mukul as an adjunct to dietary therapy in patients with hypercholesterolemia. Cardiovasc Drugs Ther. 1994; 8: 659-664
17. Andersen MR., Bowen D., Yasui Y., McTiernan A. Awareness and concern about ovarian cancer among women at risk because of a family history of breast or ovarian cancer. Am J Obstet Gynecol. 2003; 189
18. Lerman C., Schwartz M.: Adherence and psychological adjustment among women at high risk for breast cancer. Breast Cancer Research and Treatment. 1993; 28: 145-155
19. Andersen MR., Smith R., Meischke H., Bowen D., Urban N. Breast cancer worry and mammography use by women with and without a family history in a population-based sample. Cancer Epidemiol Biomarkers Prev. 2003; 12: 314-320
20. Bowen D., Burke W., McTiernan A., Yasui Y., Andersen MR. Breast cancer risk counseling improves women's functioning. Patient Educ Couns. 2004; 53: 79-86
21. Andersen MR., Nelson J., Peacock S, et al. Worry about cancer risk and use of screening by high risk women: how you recruit affects what you find. Am J Med Genetics. 2004; Part A 129: 130-135
22. Lerman C., Trock B., Rimer BK, et al.: Psychological and behavioral implications of abnormal mammograms. Ann Intern Med. 1991; 114: 657-662
23. Andersen MR., Drescher CW., Zheng Y, et al. Changes in cancer worry associated with participation in ovarian cancer screening. Psychooncol. 2007; 16: 814-820
24. Andersen MR., Peacock S., Nelson J, et al. Worry about ovarian cancer risk and use of ovarian cancer screening by women at risk for ovarian cancer. Gynecol Oncol. 2002; 85: 3-8
25. Andrich D. (ed): Rasch Models for Measurement. Beverly Hills, CA: Sage Publications; 1988
26. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing. http://www.R-project.org
27. Meiser B., Halliday JL. What is the impact of genetic counseling in women at increased risk for developing hereditary breast cancer ? Social Science & Medicine. 2002; 54: 1463-1470
28. Andersen MR., Nelson J., Peacock S, et al. Worry about ovarian cancer risk and use of screening by high-risk women: how you recruit affects what you find. Am J Med Genetics A. 2004; 129A: 130-135
29. Braithwaite D., Emory J., Walter F., Prevost AT., Sutton S. Psychological impact of genetic counseling for famillial cancer: a systematic review and meta-Analysis. JNCI. 2004; 96: 122-133
30. McGovern PG., Lurie N., Margolis KL., Slater JS. Accuracy of self-report of mammography and Pap smear in a low-income urban population. Am J Prevent Med. 1998; 14: 201-208
31. Love RR., Evans AM., Josten DM. The accuracy of patient reports of a family history of cancer. J Chronic Dis. 1985; 38: 289-293